Elexacaftor/tezacaftor/ivacaftor-real-world clinical effectiveness and safety. A single-center Portuguese study

OBJECTIVE: To evaluate the effectiveness of treatment with elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) and to characterize its safety profile in cystic fibrosis (CF) patients in a real-world clinical setting. METHODS: This was a prospective observational study carried out in a CF referral center...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes, Kelly, Custódio, Catarina, Lopes, Carlos, Bolas, Raquel, Azevedo, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970613/
https://www.ncbi.nlm.nih.gov/pubmed/36820745
http://dx.doi.org/10.36416/1806-3756/e20220312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970613/
https://www.ncbi.nlm.nih.gov/pubmed/36820745
http://dx.doi.org/10.36416/1806-3756/e20220312

Ejemplares similares